IL44774A - Pharmaceutical composition containing acetyl salicyclic acid - Google Patents
Pharmaceutical composition containing acetyl salicyclic acidInfo
- Publication number
- IL44774A IL44774A IL44774A IL4477474A IL44774A IL 44774 A IL44774 A IL 44774A IL 44774 A IL44774 A IL 44774A IL 4477474 A IL4477474 A IL 4477474A IL 44774 A IL44774 A IL 44774A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical preparation
- bicarbonate
- carbonate
- salicylic acid
- acetyl salicylic
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000008194 pharmaceutical composition Substances 0.000 title description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 claims abstract description 27
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 238000004090 dissolution Methods 0.000 claims abstract description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 7
- 230000037406 food intake Effects 0.000 claims abstract description 7
- 239000002552 dosage form Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 9
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims abstract 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- -1 alkali metal bicarbonate Chemical class 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 31
- 235000013336 milk Nutrition 0.000 abstract description 17
- 239000008267 milk Substances 0.000 abstract description 17
- 210000004080 milk Anatomy 0.000 abstract description 17
- 239000007787 solid Substances 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 abstract 1
- 150000008041 alkali metal carbonates Chemical class 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000003628 erosive effect Effects 0.000 description 7
- 230000006866 deterioration Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000013861 fat-free Nutrition 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229960001860 salicylate Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 238000012935 Averaging Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960004025 sodium salicylate Drugs 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036765 blood level Effects 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- NZRDKNBIPVLNHA-UHFFFAOYSA-N 5-Acetylsalicylic acid Chemical compound CC(=O)C1=CC=C(O)C(C(O)=O)=C1 NZRDKNBIPVLNHA-UHFFFAOYSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000690623 Doras Species 0.000 description 1
- 206010017788 Gastric haemorrhage Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 229940058671 bayer aspirin Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 229940104746 magnesium carbonate 100 mg Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL44774A IL44774A (en) | 1974-05-06 | 1974-05-06 | Pharmaceutical composition containing acetyl salicyclic acid |
| US05/571,430 US4003989A (en) | 1974-05-06 | 1975-04-24 | Pharmaceutical preparation |
| SE7504882A SE414111B (sv) | 1974-05-06 | 1975-04-28 | Forfarande for framstellning av ett farmaceutiskt preparat innehallande acetylsalicylsyra |
| AU80774/75A AU503499B2 (en) | 1974-05-06 | 1975-05-02 | Solubilized aspirin |
| DE19752519528 DE2519528A1 (de) | 1974-05-06 | 1975-05-02 | Arzneimittel fuer die orale verabreichung |
| GB18562/75A GB1483840A (en) | 1974-05-06 | 1975-05-02 | Pharmaceutical preparation containing acetylsalicylic aci |
| ZA00752867A ZA752867B (en) | 1974-05-06 | 1975-05-02 | Pharmaceutical composition containing salicylates |
| FR7513778A FR2269958B1 (sv) | 1974-05-06 | 1975-05-02 | |
| JP50053816A JPS5740122B2 (sv) | 1974-05-06 | 1975-05-02 | |
| CA226,235A CA1050889A (en) | 1974-05-06 | 1975-05-05 | Pharmaceutical preparation containing asa and milk powder |
| NL7505303A NL7505303A (nl) | 1974-05-06 | 1975-05-06 | Werkwijze voor het bereiden van een nieuw farmaceutisch preparaat. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL44774A IL44774A (en) | 1974-05-06 | 1974-05-06 | Pharmaceutical composition containing acetyl salicyclic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL44774A0 IL44774A0 (en) | 1974-07-31 |
| IL44774A true IL44774A (en) | 1977-07-31 |
Family
ID=11047667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL44774A IL44774A (en) | 1974-05-06 | 1974-05-06 | Pharmaceutical composition containing acetyl salicyclic acid |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4003989A (sv) |
| JP (1) | JPS5740122B2 (sv) |
| AU (1) | AU503499B2 (sv) |
| CA (1) | CA1050889A (sv) |
| DE (1) | DE2519528A1 (sv) |
| FR (1) | FR2269958B1 (sv) |
| GB (1) | GB1483840A (sv) |
| IL (1) | IL44774A (sv) |
| NL (1) | NL7505303A (sv) |
| SE (1) | SE414111B (sv) |
| ZA (1) | ZA752867B (sv) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE15329T1 (de) * | 1981-08-28 | 1985-09-15 | Nestle Sa | Pharmazeutische grundmasse und praeparate. |
| US4861797A (en) * | 1987-10-15 | 1989-08-29 | Oratech Pharmaceutical Development Corporation | Liquid ibuprofen compositions and methods of making them |
| GB8805757D0 (en) * | 1988-03-10 | 1988-04-07 | Rca Licensing Corp | Protection circuit for horizontal deflection circuits |
| US4960591A (en) * | 1989-04-17 | 1990-10-02 | Gribou Henry G | Methods and compositions for relief of stomach distress |
| US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| HU227496B1 (en) * | 2001-11-16 | 2011-07-28 | Zoltan Dardai | Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis |
| EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| US8435982B2 (en) * | 2007-11-30 | 2013-05-07 | Pharmathen S.A. | Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof |
| EP2512504A4 (en) * | 2009-12-15 | 2013-06-19 | Dec Int Nz Ltd | COMPOSITION AND THERAPEUTIC METHOD |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2211485A (en) * | 1940-08-13 | Effervescent acetyl salicylic acid | ||
| US3136692A (en) * | 1961-06-30 | 1964-06-09 | Strong Cobb Arner Inc | Effervescent composition containing polyvinylpyrrolidone |
| US3608064A (en) * | 1969-10-07 | 1971-09-21 | Anthony H Lamb | Milk-buffered aspirin |
-
1974
- 1974-05-06 IL IL44774A patent/IL44774A/en unknown
-
1975
- 1975-04-24 US US05/571,430 patent/US4003989A/en not_active Expired - Lifetime
- 1975-04-28 SE SE7504882A patent/SE414111B/sv not_active IP Right Cessation
- 1975-05-02 GB GB18562/75A patent/GB1483840A/en not_active Expired
- 1975-05-02 AU AU80774/75A patent/AU503499B2/en not_active Expired
- 1975-05-02 FR FR7513778A patent/FR2269958B1/fr not_active Expired
- 1975-05-02 JP JP50053816A patent/JPS5740122B2/ja not_active Expired
- 1975-05-02 DE DE19752519528 patent/DE2519528A1/de active Granted
- 1975-05-02 ZA ZA00752867A patent/ZA752867B/xx unknown
- 1975-05-05 CA CA226,235A patent/CA1050889A/en not_active Expired
- 1975-05-06 NL NL7505303A patent/NL7505303A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1050889A (en) | 1979-03-20 |
| AU8077475A (en) | 1976-11-04 |
| SE7504882L (sv) | 1975-11-07 |
| FR2269958A1 (sv) | 1975-12-05 |
| DE2519528C2 (sv) | 1989-09-21 |
| JPS5144621A (sv) | 1976-04-16 |
| DE2519528A1 (de) | 1975-11-20 |
| SE414111B (sv) | 1980-07-14 |
| ZA752867B (en) | 1976-04-28 |
| US4003989A (en) | 1977-01-18 |
| NL7505303A (nl) | 1975-11-10 |
| AU503499B2 (en) | 1979-09-06 |
| IL44774A0 (en) | 1974-07-31 |
| FR2269958B1 (sv) | 1978-06-30 |
| GB1483840A (en) | 1977-08-24 |
| JPS5740122B2 (sv) | 1982-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950002883B1 (ko) | 발포성 커플의 제조방법 | |
| EP1931222B1 (en) | Gelling compositions and methods | |
| BE1007686A4 (fr) | Nouvelles compositions pharmaceutiques a base de sels de calcium. | |
| JPH0482832A (ja) | 医薬組成物 | |
| IL44774A (en) | Pharmaceutical composition containing acetyl salicyclic acid | |
| CZ263694A3 (en) | Stable hydrated dry pulverized cephalosporin suitable for oral application in the form of a suspension | |
| US20030049335A1 (en) | Edible compositions comprising freeze-dried flavoring agents | |
| CZ225893A3 (en) | Chewing antacid preparation | |
| TW505525B (en) | Pharmaceutical compositions based on diclofenac | |
| US3485920A (en) | Analgesic compositions of aspirin and pectin | |
| NO152892B (no) | Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon | |
| US20070092561A1 (en) | Water-Soluble Aspirin Composition | |
| CA1201383A (en) | Antacid composition and process for its preparation | |
| JPH05255126A (ja) | 苦味低減組成物 | |
| US4515805A (en) | Soluble sodium cromoglycate compositions | |
| IE53830B1 (en) | Pharmaceutical carrier and compositions | |
| Beena et al. | Development and characterization of orally dissolving tablet of a poorly soluble antiemetic drug | |
| GB2086227A (en) | Sodium cromoglycate reconstitutable powders | |
| Reddy | Formulation and Evaluation of Roxatidine Acetate Fast Dissolving Tablets | |
| EP0089198A2 (en) | Nontoxic aspirin-containing composition | |
| JP2023095805A (ja) | 医薬組成物、並びにピレンゼピン塩酸塩水和物及びアズレンスルホン酸ナトリウム水和物の安定化方法 | |
| JP3088111B2 (ja) | サポニン含有アルコール吸収抑制剤 | |
| IL105870A (en) | Soft Pharmaceutical Capsules Containing and Preparing Lysine Clonix | |
| GB2049418A (en) | Pharmaceutical antacid compositions | |
| JPH1053530A (ja) | センノシドカルシウム水溶液製剤 |